- In September 2024, Knack Global announced the acquisition of Merrick Management, Inc., a provider of revenue cycle management solutions for anesthesia practices, marking a significant expansion of Knack’s offerings into the anesthesia market as Merrick’s experienced management team is expected to continue to play a pivotal role in leading Knack’s newly formed Anesthesia Services division.
- In January 2024, GlaxoSmithKline (GSK) strategically acquired Aiolos Bio, a biopharmaceutical company focused on innovative asthma treatments. Aiolos Bio's advanced pipeline of therapies for respiratory and inflammatory conditions offered GSK promising opportunities for growth and enhanced patient care
